Columvi 10 mg/10 mL (Glofitamab-gxbm Vials) 10 mg/10 mL

Columvi 10 mg/10 mL (glofitamab-gxbm) is a prescription medication used in cancer treatment. This vial form contains 10 mg per 10 mL for intravenous use. Learn about its uses, effects, and safety considerations before use.

Strength

10 mg/10 mL

Manufacturer / TM Owner

Genentech, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Columvi 10 mg/10 mL (glofitamab-gxbm) is used to treat certain types of cancer, including relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma. It belongs to a class of medications called bispecific antibodies, designed to target cancer cells. Patients often ask, 'what is Columvi used for' in managing specific blood cancers. This treatment is typically administered under medical supervision.

Side Effects

Columvi 10 mg/10 mL may cause side effects such as cytokine release syndrome, fatigue, or rash. Some patients experience infusion-related reactions, which can include fever or chills. These effects vary by individual and are monitored during treatment. Always discuss any concerns with a healthcare provider.

Precautions & Warnings

Columvi 10 mg/10 mL is for intravenous use only and should be handled by healthcare professionals. Patients with active infections or certain medical conditions may need special consideration. Keep the vial refrigerated and protect it from light. Do not use if the solution is discolored or contains particles.

Avoid Interactions

Columvi 10 mg/10 mL may interact with other medications that affect the immune system, such as corticosteroids or immunosuppressants. Live vaccines should be avoided during treatment. Always inform your doctor about all medications and supplements you are taking. Some interactions may require dose adjustments or monitoring.

References

Frequently Asked Questions

Columvi is given as an intravenous infusion by a healthcare provider in a clinical setting. The dosing schedule depends on your treatment plan.

Common side effects include cytokine release syndrome, fatigue, and rash. Your doctor will monitor you for reactions during and after infusion.

Patients with active infections may need to delay treatment. Discuss your medical history with your healthcare provider before starting Columvi.

Columvi is a treatment option for certain cancers but is not a cure. It helps manage the disease and may be used in combination with other therapies.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.